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Abstract
The objective of this work was to evaluate the solution stability of the EC1 domain of E-cadherin
under various conditions. The EC1 domain was incubated at various temperatures (4, 37, and 70
°C) and pH values (3.0, 7.0, and 9.0). At pH 9.0 and 37 or 70 °C, a significant loss of EC1 was
observed due to precipitation and a hydrolysis reaction. The degradation was suppressed upon
addition of DTT, suggesting that the formation of EC1 dimer facilitated the EC1 degradation. At 4
°C and various pH values, the EC1 secondary and tertiary showed changes upon incubation up to
28 days, and DTT prevented any structural changes upon 28 days of incubation. Molecular
dynamics simulations indicated that the dimer of EC1 has higher mobility than does the monomer;
this higher mobility of the EC1 dimer may contribute to instability of the EC1 domain.
INTRODUCTION
E-cadherin is a member of the cadherin family found in the adherens junctions of the
epithelial and endothelial cells of the intestinal mucosa and the blood-brain barrier,
respectively. The extracellular-1 (EC1) domain of cadherins is one of the most important
domains for the homophilic selectivity of cadherins.1–5 E-cadherins form homophilic
interactions on the lateral surface of the same cell as well as the opposing cells. The X-ray
structure of the entire extracellular domain of C-cadherin3 and electron tomography of
demosomes in the adherens junctions6 indicate that the EC1 domain forms cis-dimer with
the EC2 domain of another molecule from the same cell surface. The EC1 domain of C-
cadherin from one cell surface also interacts with the EC1 domain of another molecule from
the opposing cell to produce a trans-dimer.3,6 It was also proposed that the formation of the
cis-dimer of E-cadherin is necessary for the formation of the trans-dimer in cell-cell
adhesion process.5,7 E-cadherin-mediated homophilic cell-cell adhesion can be inhibited by
EC1-derived peptides,8,9 and these peptides temporarily open the intercellular junctions of
MDCK monolayers to enhance the transport of 14C-mannitol.10,11 The EC1 domain has also
been shown to play an important role in the heterophilic binding of E-cadherin to αEβ7
integrin expressed predominantly on the surface of intraepithelial T lymphocytes at the
intestine.12 The site of heterophilic interaction of EC1 with αEβ7 is different than that for the
homophilic interaction with E-cadherin.12 Although the EC1 domain has been shown to
modulate E-cadherin-mediated Caco-2 cell-cell adhesion,9 the expressed EC1 protein cannot
be stored for a long period of time in solution because it is unstable. Therefore, it was
necessary to study the stability properties of the EC1 domain before we could find a
method(s) to stabilize this molecule for future biological studies.
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To study the stability of EC1 in solution, we expressed the EC1 domain (105 residues; MW
= 11,628 Da) without the calcium-binding sequence found at the interface between EC1 and
EC2 domains. Because EC1 was expressed with His-tag, the expressed EC1 domain has four
additional amino acids (GSHM) at the N-terminus. Addition of these four amino acids does
not change the secondary structure of EC1 as determined by CD. In this case, the Cys9
residue on the native EC1 is at Cys13 on the EC1 domain studied here (Figure 1).13 The
monomeric form of the EC1 domain can readily produce a covalent dimer via an
intermolecular disulfide bond of Cys13 residues followed by the generation of physical
oligomers and precipitates.14 This creates problems in studying the biological activity of the
EC1. Our hypothesis is that blocking the formation of the covalent dimer may inhibit the
oligomerization and precipitation of the EC1 domain. Therefore, the goal of this study was
to investigate the effect of covalent dimerization on the oligomerization and precipitation as
well as the chemical stability of EC1. Stabilization of the monomer will help our effort in (a)
elucidating the mechanism of interaction between the EC1 domain and other expressed
domains (EC2, EC3, EC4, and EC5) of E-cadherin, (b) evaluating the activity of the EC1
domain in blocking homotypic and heterotypic cell-cell adhesion, and (c) determining the
binding site(s) of E-cadherin peptides on the EC1 domain by NMR spectroscopy.
Furthermore, EC1 is a good model for studying methods of inhibiting the oligomerization
and precipitation processes of proteins in formulation.
In this work, we studied the accelerated physical and chemical stability of the EC1 domain
at different temperatures and pH values in the absence and presence of dithiothreitol (DTT).
The chemical degradation process was evaluated by HPLC and mass spectrometry (MS).
The effect of pH and incubation time on the secondary structure was evaluated by CD
spectroscopy. The intrinsic fluorescence emission of EC1 was monitored to follow the
changes in the tertiary structure of EC1 upon incubation under different conditions.
Molecular dynamics simulations were used to investigate the dynamic properties of the EC1
monomer and dimer. The results indicated that the formation of the EC1 dimer is critical to
the physical and chemical stability of EC1.
EXPERIMENTAL METHODS
Expression of EC1
Competent E. coli cells were transformed with pET-15b vector ligated to cDNA of EC1 and
grown in LB medium at 37 °C and 250 rpm shaking. When the UV absorbance of the E. coli
reached 0.5 units at 600 nm, the cells were induced with isopropyl-β-D-
thiogalactopyranoside (IPTG). The growth of the cells was monitored until their UV
absorbance at 600 nm reached a plateau (usually about 1.5 units after 3 h). The E. coli cells
were then harvested by centrifugation at 8,000 rpm for 6 min. The pellets obtained were
resuspended in a buffer containing 100 mM Tris, 100 mM NaCl, and 2.0 mM β-
mercaptoethanol (BME) at pH 8.0. The suspension of cells was passed through a French cell
press at a pressure of greater than 1000 psi to lyse the cells and release the expressed EC1
into the buffer.15 The lysed cell suspension was then centrifuged for 45 min at 20,000 rpm
and 4 °C to separate the insoluble cell debris from dissolved EC1. The supernatant obtained
in this manner was further cleared of any particulate matter by passing it through a 0.45
micron filter. The EC1 obtained in this manner has a His-tag on its N-terminus.
Purification of EC1 Protein
The lysed cell suspension containing EC1 with His-tag (EC1-Histag) was loaded onto a Hi
trap nickel affinity column (GE Healthcare).15 This was followed by elution with washing
buffer containing 100 mM Tris and 100 mM NaCl at pH 8.0 with increasing concentration
of imidazole (from 10 mM to 50 mM) to wash off other non-specifically bound proteins.
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The EC1-Histag protein bound to the nickel affinity column was then eluted by increasing
the concentration of imidazole to 150 mM. The fraction of eluted EC1-Histag was dialyzed
against buffer containing 20 mM Tris, 100 mM NaCl, and 10 mM EDTA at pH 8.0 to
remove any residual nickel and imidazole. Next, the EC1-Histag solution was dialyzed
against buffer containing 20 mM Tris and 100 mM NaCl at pH 8.0 to remove the EDTA.
The pure EC1-Histag was concentrated to 1.0 mL followed by dilution with 8.0 mL of
deionized water. To 8.0 mL of diluted protein, thrombin (0.5 units/mg of EC1-Histag) was
added in cleavage buffer (200 mM Tris, 1.5 M NaCl, 25 mM CaCl2, 2 mM BME) and the
mixture was incubated with gentle shaking for 2 h at room temperature to cleave the Histag
from the EC1 domain without cleaving any other sequence within EC1. At the end of 2 h
incubation, the mixture was run through a benzamidine column to trap the thrombin; a
mixture of EC1 and cleaved Histag was eluted from the column using buffer (20 mM Tris,
100 mM NaCl, 2 mM BME) at pH 8.0. The eluted mixture was then passed through the
nickel affinity column to separate the pure EC1 from the Histag. The pure EC1 was obtained
and dialyzed in a buffer containing 20 mM Tris, 100 mM NaCl, 2 mM BME, and 10 mM
EDTA at pH 8.0 to remove any residual nickel. Finally, the EC1 solution was dialyzed
against a buffer containing 20 mM Tris, 100 mM NaCl, and 2 mM BME at pH 8.0 to
remove any remaining EDTA. SDS-PAGE of the protein was run to confirm its purity, and
the identity of EC1 was evaluated by ESI positive mode time-of-flight (TOF) MS with a
molecular weight of 11,628 Da.
Chemical Stability Studies
Chemical stability studies of 86 μM EC1 (1.0 mg/mL) were carried out at pH 3.0, 7.0, and
9.0 and temperatures of 4, 37, and 70 °C. The buffers used were 100 mM phosphate for pH
3.0, 50 mM phosphate for pH 7.0, and 100 mM borate with 0.08 M NaCl for pH 9.0. EC1
was dialyzed into each buffer using Amicon centrifugal filter devices containing a
membrane with a molecular weight cut-off of 10,000 Da. Samples containing the EC1
protein at different pH values were incubated at 4, 37, or 70 °C in the absence and presence
of 0.1 M DTT. The molar ratio of DTT: EC1 in these studies is approximately 10,000:1,
which is sufficient to maintain EC1 in its reduced monomeric form. Three samples were
drawn out at each time interval and immediately frozen at −70 °C prior to analysis. Each of
the frozen samples was thawed and centrifuged at 12,000 × g for 10 min at 4 °C to remove
any particles before HPLC analysis as described below.
The degradation profiles of the EC1 protein were evaluated using SDS PAGE gel and an
HPLC system (Dynamax SD-200). The sample (25 μL) was injected onto an analytical
HPLC column (C18, Varian Microsorb, pore-size 300Å, dimensions 250 × 4.6 mm) using
gradient elution with a rate of 1.0 mL/min. Solvent A (94.9% double distilled water, 5%
acetonitrile (ACN), and 0.1% TFA) and solvent B (100% ACN) were used in various
proportions for the separation and resolution of eluting peaks. The sequence of the gradient
elution was as follows: 0% B to 45% B for 2.0 min, 45% B to 51% B for 10.0 min, 51% B
to 51% B for 5.0 min, 51% B to 100% B for 2.0 min, and 100% B to 100% B over 2.0 min,
and 100% B to 0% B over 1.0 min. The eluted protein and its degradation products were
detected using a Varian Prostar UV detector at a wavelength of 220 nm. The degradation
products were identified by LCMS utilizing a C4 micro-column with ESI positive mode and
TOF detection methods.
Physical Stability Studies
Long-term physical stability studies of EC1 were performed at a concentration of 86 μM
(1.0 mg/mL) and pH 3.0, 7.0, and 9.0 under the same conditions as used in the chemical
stability studies (see above). The sealed EC1 samples (300 μL in each vial) were stored at 4
°C for 14 or 28 days in the absence and presence of 2.0 mM DTT. The CD spectra of the
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samples prior to incubation (day 0) and after incubation were collected in the far-UV
spectrum (200–250 nm) at 1 nm bandwidth and 0.1 cm pathlength using a Jasco
spectropolarimeter (J-720) equipped with a Peltier temperature controller. The thermal
unfolding profile of the protein samples was monitored in two ways: 1) by collecting CD
spectra every 5 °C while increasing the temperature from 10 to 65 °C at the rate of 15 °C per
hour after equilibrating the sample for 300 s at each temperature, and 2) by monitoring the
CD signal at 218 nm (for change in β-sheet structure) after every 0.5 °C rise in
temperature.16 Each sample was run in triplicate, and a blank sample spectrum containing
the buffer alone was subtracted from each sample spectrum. The ellipticity value at 218 nm
was plotted for each temperature point to examine the thermal unfolding profile of the
sample. This plot was fitted to a sigmoidal function using Origin 7.0 software, and the
midpoint of each plot was taken as the thermal unfolding (denaturation) temperature.
For fluorescence spectroscopy studies, 1.0 mL 86 μM EC1 (1 mg/mL) was incubated at pH
values of 3.0, 7.0 and 9.0 each for a period of 28 days at 4 °C. At days 0, 14, and 28, EC1
(0.3 mL) was withdrawn from the incubated samples and diluted to 0.1 mg/mL with buffer
of the corresponding pH. This solution (0.9 mL) was loaded into a quartz fluorescence
cuvette of 1 cm pathlength and intrinsic fluorescence spectra were collected on a PTI
QuantaMaster spectrofluorometer at 2.5 °C intervals from 10 to 87.5 °C. The analyte was
equilibrated for 5 min at every temperature prior to the spectrum collection. An emission
spectrum was obtained from 305 nm to 405 nm after excitation of the analyte at 295 nm
(>95% Trp emission).17 The excitation and emission slits were adjusted so that the emission
at its maximum was between 500,000 and 1,000,000 counts/s. Each experiment was
performed in triplicate, and the appropriate buffer was also run as a control.
The entire analysis described above was repeated in the presence of 2.0 mM DTT. To
analyze the data, the signals from the blanks were subtracted from emission spectra of the
samples. Each fluorescence emission spectrum obtained was fitted to an extreme
asymmetric peak function using the non-linear curve-fitting wizard of Origin 7.0 software to
obtain the wavelength of maximum emission. The wavelength of maximum emission at each
temperature was plotted against temperature to calculate the transition temperature.
Computer Simulations and Molecular Modeling
Molecular dynamics simulations of the EC1 monomer of E-cadherin (PDB code:
1EDH)18,19 and the EC1 dimer containing a disulfide bond were performed for 10 ns using
Nanoscale Molecular Dynamics 2.6 (NAMD 2.6).20 Both systems were solvated by cubic
boxes of TIP3P water with a margin of ~15 Å between the protein and the boundaries of the
periodic box. Na+ and Cl− counterions were added to neutralize the system. Protein, water,
and ions were modeled with the CHARMM 22 force field.20 The particle mesh Ewald
method was used to treat long-range electrostatic interactions. Periodic boundary conditions,
10 Å cutoff, and a switching cutoff distance of 8 Å for nonbonded van der Waals
interactions were applied. All bonds involving hydrogen atoms were constrained using the
SHAKE algorithm and a time-step of 2 fs was employed to integrate the equations of
motion. The equilibration stage includes energy minimization of protein for 5,000 steps
followed by minimization of the complete system for 10,000 steps to remove close contacts.
Finally, the entire system was subjected to a gradual temperature increase from 0 to 300 K in
intervals over 30 ps by increasing the temperature of Langevin damping and Langevin
piston by 30 K in each step. The complete system was then equilibrated for 300 ps. Pressure
and temperature were maintained at 1 atm and 300 K using a Langevin barostat and
Langevin thermostat.
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Chemical Stability of EC1
The EC1 protein was incubated in the presence and absence of 0.1 M DTT at pH 3.0, 7.0,
and 9.0 at 4, 37, and 70 °C. Samples were drawn out at 0.5, 1, 2, and 4 h time-points and the
supernatant after centrifugation of each sample at 12,000 × g was injected into the HPLC
system. The decrease in the area under the EC1 peak as well as the increase in the area under
any new peaks, if present, were monitored. Degradation products, represented by new peaks,
were identified using LCMS (ESI-TOF).
The EC1 protein was stable when incubated at 4 °C for 4 h at pH values of 3.0, 7.0, and 9.0
(data not shown). There was no observable difference in the stability of EC1 in the absence
and presence of DTT, suggesting that the protein was stable at low temperature.
The EC1 protein was stable at pH 3.0 for 4 h at 37 °C, and it was difficult to distinguish the
effect of DTT on the stability of EC1 (Figure 2A). At pH 7.0, the amount of EC1 decreased
to about 75.1 ± 14.9% after 4 h in the absence of DTT (Figure 2B). In contrast, the decrease
of EC1 after 4 h in the presence of DTT at pH 7.0 was to about 94.4 ± 5.9% (Figure 2B).
There was no observable chemical degradation product at pH 7.0 as monitored by HPLC;
thus, the disappearance of the starting protein was due to physical degradation (i.e., protein
aggregation and precipitation) (Figure 2B), implying that prevention of covalent dimer
formation inhibits the precipitation of EC1.
At pH 9.0, however, a chemical degradation product appeared over time (Figure 2C) with a
molecular weight of 10,386 Da as determined by ESI positive TOF-MS (data not shown).
The degradation product corresponds to a protein fragment resulting from the cleavage of
the peptide bond between the Asp93 and Pro94 residues (Figure 1). In the absence and
presence of DTT, the amounts of the degradation product were around 28.0 ± 1.3% and 12 ±
1.3%, respectively, indicating that DTT suppressed the degradation of EC1. There was no
precipitation observed at pH 9.0 with a good mass balance between the remaining EC1 and
the degradation product in solution.
The degradation of EC1 at pH 3.0 and 70 °C was rapid compared to that at 4 and 37 °C with
about 25.1 ± 9.4% and 5.5 ± 1.5% of EC1 remaining in solution after 2 h and 4 h incubation,
respectively (Figure 3A). After 30 min, the degradation product of Asp93-Pro94 hydrolysis
with a molecular weight of 10,386 Da was observed as was previously found at pH 9.0 and
37 °C. The size exclusion chromatography (SEC) could not separate the EC1 domain and
the degradation product due to the small molecular weight difference between the two
molecules. Because EC1 and the degradation product could be readily separated by C18
reversed-phase HPLC, the amounts of remaining EC1 and the degradation product(s) were
determined by reversed-phase HPLC. An increase in the degradation product, from 19.6 ±
3.7% to 38.5 ± 15.1%, was seen during 0.5 to 2.0 h incubation followed by a drop in product
amount to 12.2 ± 11.6% at the 4 h incubation time. The decrease in the amount of the
degradation product in solution upon incubation longer than 2 h could be due to the
precipitation of the product along with the EC1 covalent dimer. Here, it was found that DTT
decreased the precipitation and completely suppressed the peptide bond hydrolysis
degradation (Figure 3A).
At pH 7.0 in the absence of DTT, the remaining of EC1 after incubation for 2 h and 4 h was
found to be 66.5 ± 1.7% and 14.7 ± 5.0%, respectively (Figure 3B), with two observed
degradation products (1 and 2). The degradation product 1 was due to hydrolysis of at the
Asp93 and Pro94 residue of EC1 and further degradation of product 1 generated product 2.
Similar to pH 3.0, the disappearance of EC1 and the formation of the degradation products
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in solution did not produce a mass balance, suggesting that the degradation of EC1 involved
the precipitation of the EC1 dimer and the degradation product. The addition of DTT
inhibited the rate of peptide bond hydrolysis as well as the precipitation of EC1.
EC1 had the greatest amount of chemical degradation product at pH 9.0 with 54.8 ± 3.0% of
the degradation after 4 h incubation (Figure 3C) compared to that at pH 3.0 and 7.0. Again,
the production of the peptide bond hydrolysis product was suppressed by the presence of
DTT. In addition, the amount of starting material remaining in solution was higher at pH 9.0
than at pH 3.0 or 7.0 at the 4 h time point, which suggests less precipitation of EC1 at pH
9.0 than at pH 3.0 and pH 7.0.
Physical Stability of EC1
Secondary structure evaluation using CD—At pH 3.0, the CD spectrum of EC1 has
a negative peak around 216 nm before incubation (Figure 4A, day 0), suggesting that it has a
predominantly β-sheet structure. This is consistent with the known structures of EC
domains. Addition of DTT caused some change in the secondary structure of EC1. Upon
storage of EC1 for 14 days at 4 °C without DTT, its CD spectrum was dramatically changed
compared to the original spectrum and showed increasing β-sheet character. This could be
due to oligomerization via β-sheet intermolecular interactions. Addition of DTT suppressed
the change in the CD spectra of EC1 between day 0 and day 14 (Figure 4A), demonstrating
that DTT inhibits the aggregation of the EC1 protein. At pH 7.0 (Figure 4B) and pH 9.0
(Figure 4C), the CD spectral changes were less dramatic than that at pH 3.0 (Figure 4A).
The major changes in the CD spectra of EC1 at pH 7.0 after incubation for 14 and 28 days
without DTT were in the minimum at 216 and the maximum at 205 nm (Figure 4B).
Addition of 2.0 mM DTT to the buffer suppressed the spectral change upon incubation for
28 days. There were no observable changes in the CD spectra of EC1 at pH 9.0 after 28 days
in the presence and absence of DTT (Figure 4C).
The melting curves of EC1 were monitored at 218 nm and compared in the absence and
presence of DTT (Figure 5). At pH 3.0 without DTT, the melting curves of EC1 were
dramatically different between day 0 and day 14, with a more negative ellipticity minimum
at day 14 than that at day 0 (Figure 5A). The melting temperatures (Tm) were 28.8 °C on day
0 and 33.1 °C on day 14, indicating that the protein could form oligomers with a higher Tm.
In contrast, the thermal unfolding curves of EC1 on days 0 and 14 were very similar in the
presence DTT (Figure 5A). At the final melting temperature, the protein solution with DTT
had a lower absorbance minimum than that of protein without DTT, indicating that the β
structure of the protein at high temperature in the absence of DTT was increased compared
to that in the presence of DTT.
At pH 7.0, thermal unfolding of EC1 at days 0, 14, and 28 in the presence of DTT did not
show a difference in melting temperature (Tm = 44.6 °C, Figure 5B). Without DTT, thermal
unfolding curves at pH 7.0 gradually shifted from day 0 to day 28 with an increase in initial
and final ellipticities; this result is different than the one observed at pH 3.0, suggesting that
the structures of the intermediates at pH 7.0 are different than those at pH 3.0. The presence
of DTT prevented the change in thermal unfolding curves over time, again suggesting that
DTT prevented the physical degradation of EC1. Thermal denaturation of EC1 at pH 9.0
produced a Tm at 37.8 °C (Figure 5C) with a slightly higher Tm after incubation up to day
28. At pH 9.0, DTT did not have a dramatic effect on the melting curve profiles of the EC1
domain at different time points.
Evaluation of tertiary structural change by fluorescence spectroscopy—The
intrinsic fluorescence emission spectrum of EC1 at pH 3.0 on day 0 without DTT showed a
maximum emission at 339.93 ± 0.04 nm. There was no observable change upon incubation
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for 14 days (data not shown). After 28 days, a slight blue shift to 337.09 ± 0.04 nm in the
maximum emission was observed, implying that the Trp residue environment became more
apolar. In the presence of DTT on day 0, EC1 showed an emission profile (339.85 ± 0.04
nm) similar to that in the absence of DTT. A blue shift to 337.35 ± 0.04 nm was also
observed after incubation for 28 days. At pH 7.0 without DTT, the emission maximum was
339.27 ± 0.03 nm; after incubation for 28 days, there was a considerable red shift in the
emission maximum to 345.81 ± 0.13 nm, presumably due to the solvent exposure of the Trp
residues (Figure 6A). The presence of DTT inhibited the red shift in the emission maximum
from 339.26 ± 0.03 nm on day 0 to 340.66 ± 0.04 nm on day 28. Without DDT at pH 9.0,
the intrinsic fluorescence spectra showed a slight blue shift from 341.32 ± 0.03 nm on day 0
to 340.32 ± 0.03 nm and 340.08 ± 0.03 nm on days 14 and 28, respectively (data not
shown). In the presence of DTT, the shift in maximum emission was from 341.06 ± 0.03 nm
on day 0 to 341.19 ± 0.02 nm and 341.42 ± 0.03 nm on days 14 and 28, respectively.
The thermal transitions of EC1 at pH 3.0, 7.0, and 9.0 were also monitored by fluorescence
spectroscopy at the emission wavelength of 340 nm upon heating from 10 to 87.5 °C. At pH
3.0, there was no clear and observable transition seen in the absence or presence of DTT at
all time points (data not shown). Distinct thermal transitions, however, were observed at pH
7.0 in both the absence and presence of DTT (Figure 6B). In the absence of DTT, the
transition temperature decreased from 42.63 ± 0.56 °C at day 0 to 39.10 ± 2.31 °C at day 28.
On the other hand, relatively constant transition temperatures were observed in the presence
of DTT between day 0 (45.36 ± 0.79 °C) and day 28 (45.14 ± 0.65 °C). At pH 9.0,
transitions were observed on day 0 in the absence and presence of DTT; these transitions did
not change significantly after incubation for 28 days with and without DTT (data not
shown).
Molecular dynamics simulations of EC1 monomer and dimer—To explain the
difference between the stabilities of EC1 monomer and dimer, 10 ns equilibrium simulations
were conducted on both in solution. To explore their dynamic stability, root-mean-square
displacement (RMSD) values for the protein Cα atoms were calculated and plotted during
the production phase relative to the starting structures for EC1 monomer (Figure 7A) and
EC1 dimer (Figure 7B). The RMSD plots indicated that the structures of the EC1 monomer
(Figure 7A) achieved equilibrium much faster than those of the dimer (Figure 7B); the dimer
achieves equilibrium around 3 ns of simulations. The RMSD values of the monomer are
within 1.5 Å of those of the initial structure while the RMSDs of the dimer are in the range
of 3.5–4.0 Å. RMSDs were also plotted against the residue number for the monomer (Figure
7C) and chains A and B of the dimer (Figure 7D). The average RMSD value per residue of
the dimer is larger than that of the monomer, demonstrating that the dimer has larger overall
flexibility than the monomer. Structural snapshots of the monomer and dimer after 2, 5, 7,
and 10 ns simulations are shown in Figures 8A and 8B, respectively. All four structures of
the EC1 monomer are very stable, without noticeable differences. In contrast, there are
significant differences among the snapshot structures of the dimer, with some of the regions
showing increased dynamic properties (Figure 8B). The increased dynamic properties of the
disulfide-mediated EC1 dimer may explain the decreased chemical and physical stability of
the dimer.
DISCUSSION
Previously, EC1 was found as a mixture of monomer, dimer, and oligomers; three peaks
were observed in SEC.14 Upon isolation of each peak, the longest eluted peak (peak 3) was
identified as the monomer of EC1 and followed a middle peak (peak 2), which was
determined as a covalent dimer of EC1 (EC-ss-EC1) by SDS-PAGE, SEC, and HPLC/
dynamic light scattering. The earliest peak (peak 1) was identified as a non-covalent
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hexameric form of the covalent dimers (EC1-ss-EC1) identified by HPLC/dynamic light
scattering, electron microscopy, and crosslinking methods.14 SDS-PAGE of peak 1 showed
a protein with a dimer molecular weight, suggesting that peak 1 was derived from physical
interactions of EC1-ss-EC1. The electron microscopy study also showed other forms of
oligomers of EC1-ss-EC1 with two and more than six units of EC1-ss-EC1. Addition of
DTT to peak 1 converted the hexameric form to a monomer as identified by SEC and
dynamic light scattering. These results indicated that the formation of oligomers was
mediated by physical interactions EC1-ss-EC1. Upon mutation of the Cys residue with an
Ala residue, the dimeric and oligomeric forms of EC1 were not observed.14 The fact that
EC1 monomers do not oligomerize before forming covalent dimers leads us to hypothesize
that the structures of the EC1 monomer and covalent dimer are different. In this work, we
evaluated the chemical stability of EC1 and the changes in its structure in the absence and
presence of a reducing agent, DTT.
In general, the accelerated thermal degradation mechanism of EC1 in solution involves
chemical degradation and aggregation that leads to protein precipitation, which can be
observed visually. The mass balance between the degradation products and the remaining
starting material in solution did not add up to 100%; this difference in mass balance can be
attributed to protein precipitation. Most of the degradation profiles in different pH values
and temperatures (Figures 2 and 3) show the appearance of two different slopes, which
possibly due to two different reactions as the rate determining steps. There are at least four
different possible reactions occur in solution: (1) the formation of dimer via a disulfide
bond, (2) the hydrolysis of the Asp-Pro peptide bond, (3) the physical oligomerization of
EC1, and (4) the formation of precipitates of the higher order oligomers; however, it is
difficult to determine which reactions that are involved as the rate determining steps.
The EC1 domain also showed hydrolysis products at all pH values at 70 °C; at 37 °C, this
hydrolysis was observed only at pH 9.0. The degradation products were the result of a
peptide bond hydrolysis between Asp93 and Pro94 residues as identified by ESI MS. Base-
catalyzed hydrolysis of the Asp-Pro peptide bond has been reported previously in peptides
and proteins, including peptide bond cleavage of Asp133–Pro134 in recombinant human
interleukin 1121 and Asp169-Pro170 in recombinant human macrophage colony-stimulating
factor.22 It has been previously reported that the peptide and protein degradation
mechanisms at Asp residues were different at different pH values (acidic, neutral, and
basic).23,24 At pH <5.0, the major degradation products are derived from peptide bond
hydrolysis at the N- and C-termini of the target Asp residue via the anchimeric assistance of
the carboxylic acid side chain of the Asp residue. At neutral and basic conditions (pH >6.0),
the degradation mechanism is through a cyclic-imide intermediate formation that can
produce iso-Asp as well as related hydrolysis products.23,24 Due to the absence of the amide
hydrogen in the Asp-Pro peptide bond of EC1, the degradation of EC1 in neutral and basic
conditions cannot proceed through the cyclic-imide intermediate; therefore, it was expected
that iso-Asp product would not be observed as a degradation product of EC1. An important
finding here is that the addition of DTT suppresses or completely eliminates the Asp93-
Pro94 peptide bond hydrolysis. Because in the presence of DTT only the monomeric form
exists in solution, the results suggest that the hydrolysis of the EC1 monomer may be
catalyzed by dimeric and/or oligomeric forms of EC1. In other words, the monomeric form
is chemically more stable than the dimer and oligomer forms; thus, the EC1 domain can be
stabilized against peptide bond hydrolysis by trapping it in its monomeric form.
The effect of 4 °C storage on the secondary structure and physical stability of EC1 in the
absence and presence of DTT was evaluated by far UV CD. EC1 showed a negative CD
peak at 216 nm at all pH values, which is characteristic of β-sheet proteins. The X-ray18 and
NMR7 structures of EC1 showed that it has seven β-strands and two small α-helices. After
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storage at 4 °C for 14 days at pH 3.0 in the absence of DTT, the CD spectrum changed
dramatically, with the peak at 216 nm becoming more negative. This could imply the
generation of aggregates via the formation of intermolecular β-sheet interactions. In contrast,
there was no change in the CD spectrum after 14 days incubation in the presence of DTT,
indicating that there was no secondary structural change. It should be noted that addition of
DTT at pH 3.0 changes the spectrum of EC1 on day 0, suggesting that DTT induces a
secondary structural change in EC1 that prevents the physical degradation of EC1 at pH 3.0
upon 4 °C storage (Figures 4A and 5A). At pH 7.0 and 9.0, there were no observable
changes in the CD spectra of EC1 with DTT on day 0 and day 28. Upon incubation of EC1
in the absence of DTT, there were observable changes in the CD spectrum on day 28
compared to that on day 0.
To further differentiate the effect of DTT on the thermal stability and possible
oligomerization of EC1, thermal unfolding profiles of EC1 after incubation at 4 °C at 0, 14,
and 28 days were determined by monitoring the CD spectra at 218 nm. At pH 3.0, thermal
unfolding profiles at days 0 and 14 were very similar in the presence of DTT but were very
different in its absence. This suggests that protein structural changes (i.e., oligomerization)
occur upon incubation in the absence of DTT. In the absence of DTT at pH 7.0, CD spectra
of EC1 changed after storage for 14 and 28 days; in contrast, there was no observable
change in the presence of DTT. At pH 9.0, thermal unfolding properties of EC1 did not
change significantly upon storage at 4 °C in the absence and presence of DTT. These results
suggest that the secondary structures of the monomer and covalent dimer are very similar at
pH 9.0; however, they are different at lower pH values.
Changes in the tertiary structure of EC1 upon incubation under different conditions were
also monitored by observing the emission spectra of Trp6 and Trp63 in EC1 using
fluorescence spectroscopy. The Trp6 residue is located close to Cys13. We hypothesized
that the formation of intermolecular disulfide between two Cys13 residues can cause a
change in the conformation of EC1 that alters the environment of one or both Trp residues.
There was considerable change in the environment of at least one of the Trp residues over a
period of 28 days incubation at 4 °C and pH 3.0 and 7.0. In the case of pH 7.0, there was a
red shift indicating a more polar environment for one of both Trp residue(s); in contrast, a
blue shift was observed at pH 3.0, indicating a more apolar environment of the Trp residue.
Thus, the resulting tertiary structures or association states of EC1 were different at these two
pH values (i.e., 3.0 and 9.0). The addition of DTT prevented the fluorescence change at pH
7.0, but not at pH 3.0. This is in contrast to the CD data in which addition of DTT prevented
a change in the secondary structure of EC1 at both pH 3.0 and 7.0. The Trp6 residue has
been shown previously to be involved in domain swapping to form EC1 physical dimers,
suggesting that the fluorescence changes seen could be due to the contribution of Trp6
domain swapping upon covalent dimer formation. At pH 3.0, the rate formation of the
intermolecular disulfide may be slowed down, resulting in a predominance of domain
swapped physical dimers, which subsequently oligomerize. In such structures, the Trp6
would be expected to be buried; hence, the blue shift is observed at pH 3.0.
Our findings show that the formation of a covalent dimer induces chemical and physical
instability; in an attempt to explain this observation, the dynamic properties of the EC1
monomer and dimer were examined using computer simulations. Previously, molecular
dynamics simulations were done to determine the dynamic properties of the EC1–2 portion
of E-cadherin in the presence and absence of calcium ions. These simulations confirmed that
apo-cadherin shows much higher conformational flexibility on a nanosecond timescale than
does the calcium-bound form.25 The results from the current molecular dynamics
simulations showed that the EC1 dimer had a greater mobility than did the EC1 monomer.
Larger fluctuations were observed around residues 15, 30, 70, and 85 of the dimer compared
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to those on the EC1 monomer (Figures 7C and 7D). In the EC1 dimer, some hydrophobic
residues that would be expected to be folded into the core of the protein were found to be
solvent-exposed at the end of the molecular simulations. Intermolecular interactions of these
exposed hydrophobic residues on several EC1 dimers could be the driving force for the
formation of oligomers in solution. These dramatic conformational changes were not
observed in the simulation of the EC1 monomer; thus, keeping the EC1 domain in the
monomeric form with DTT prevents its oligomerization. The formation of a covalent dimer
could make the Asp93 and Pro94 residues more flexible and exposed to the solvent (Figure
8B), leaving the Asp93–Pro94 peptide bond susceptible to hydrolysis. These molecular
simulations data support the hypothesis that the formation of oligomers may be via the
covalent EC1 dimer, which induces a change in conformation that results in the Asp-Pro
peptide bond becoming solvent-exposed and susceptible to hydrolysis.
In conclusion, this study showed that EC1 degradation is mediated by the formation of an
EC1 covalent dimer via its Cys13 residue. Although the Asp-Pro hydrolysis and disulfide
bond formation have an important role in the degradation of EC1, other degradation
mechanisms may also occur in this protein. This covalent dimer induces a conformational
change in EC1 that is prone to produce oligomers, which lead to precipitation and facilitate
chemical hydrolysis. Thus, prevention of covalent dimer formation by alkylating the thiol
group could be an alternative method to stabilize the EC1 domain in solution without
addition of a reducing agent. The alkylation of the thiol group of Cys13 will provide an EC1
monomer that can potentially be used to block E-cadherin-mediated homotypic and
heterotypic cell-cell adhesion for use in pharmaceutical applications.
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Primary sequence of the EC1 protein obtained at the end of the purification process. The
first four residues, GSHM, are the non-native residues as a result of the type of vector used
for transfection into E. coli cells. The single Cys13 residue is equivalent to the Cys9 residue
in the native EC1. The potential hydrolysis site is also indicated. The Trp6 residue is the
potential domain-swapping residue.
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The stability profile of the EC1 domain incubated at 37 °C for 4 h in the absence and
presence of 0.1 M DTT in buffer solutions at pH (A) 3.0, (B) 7.0 and (C) 9.0. (A) There is a
small difference in the amount of EC1 remaining in the absence and presence of DTT at pH
3.0. (B) At pH 7.0 in the absence of DTT, 25% EC1 was lost after 4 h due to precipitation.
In the presence of 0.1 M DTT, the amount of EC1 decreased only about 6% after 4 h. (C) At
pH 9.0 and 37 °C in the absence of 0.1 M DTT, about 27% of EC1 degraded to form a new
product. However, in the presence of 0.1 M DTT only 13% of EC1 degraded to form the
new product.
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The stability profiles of the EC1 domain incubated at 70 °C for 4 h in the absence and
presence of 0.1 M DTT in buffer solutions at pH (A) 3.0, (B) 7.0, and (C) 9.0. At all pH
values, EC1 undergoes peptide bond hydrolysis and precipitation, and DTT suppresses the
hydrolysis reaction and decreases EC1 precipitation.
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CD spectra of EC1 in the absence and presence of DTT after incubation at 4 °C for 0, 14, or
28 days at pH (A) 3.0, (B) 7.0, and (C) 9.0. (A) In the absence of DTT at pH 3.0, EC1
undergoes secondary structural change presumably due to dimerization and oligomerization.
In the presence of DTT, there is no secondary structural change in EC1. (B) At pH 7.0 on
day 28, there is some loss of the β-sheet structure of EC1 in the absence of DTT as seen
from the decrease in the minimum at 216 nm; addition of DTT suppresses the secondary
structural change of EC1. (C) At pH 9.0 on day 28, the CD spectra remain unchanged in the
presence and absence of DTT.
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Thermal unfolding profiles of EC1 in the absence and presence of DTT measured by CD at
218 nm after incubation for 14 to 28 days at 4 °C at (A) pH 3.0, (B) 7.0, and (C) 9.0. (A) At
pH 3.0, the thermal unfolding profiles in the absence of DTT are different on day 14 than on
day 0. In the presence of DTT, the profiles look the same on days 0 and 14. (B) At pH 7.0,
the thermal unfolding profiles in the absence of DTT are different at different time points;
however, the profiles are relatively the same in the presence of DTT. (C) At pH 9.0, the
thermal unfolding profiles are comparable after incubation for 14 and 28 days in the
presence or absence of DTT.
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(A) Fluorescence spectra of EC1 in the absence and presence of DTT after incubation at 4
°C for 0 or 28 days at pH 7.0. A shift in maximum emission to a higher wavelength is
observed in the absence of DTT; however, this shift is inhibited by addition of DTT. (B)
Thermal unfolding of EC1 in the absence and presence of DTT evaluated by change in the
wavelength of maximum intrinsic fluorescence emission (after excitation at 295 nm) from 0
to 87.5 °C after incubation for 0, 14, or 28 days at 4 °C and pH 7.0. The inset is the scaled
up unfolding profile to show the inflections in different incubation conditions.
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RMSD values for 10 ns simulations of (A) EC1 monomer and (B) EC1 dimer. RMSD values
for each residue in (C) EC1 monomer and (D) both A and B chains of EC1 dimer at the end
of 10 ns equilibrium simulations.
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Snapshots of (A) EC1 monomer and (B) EC1 dimer after 2, 5, 7 and 10 ns of molecular
dynamics simulations. The arrows indicate the flexible regions of the EC1 dimer during
molecular dynamics simulations.
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